Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:XRTX

XORTX Therapeutics (XRTX) Stock Price, News & Analysis

XORTX Therapeutics logo

About XORTX Therapeutics Stock (NASDAQ:XRTX)

Advanced Chart

Key Stats

Today's Range
$0.84
$0.93
50-Day Range
N/A
52-Week Range
N/A
Volume
3.50 million shs
Average Volume
210,848 shs
Market Capitalization
$3.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

XORTX Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

XRTX MarketRank™: 

XORTX Therapeutics scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for XORTX Therapeutics.

  • Price to Book Value per Share Ratio

    XORTX Therapeutics has a P/B Ratio of 1.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.08% of the float of XORTX Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    XORTX Therapeutics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in XORTX Therapeutics has recently decreased by 75.86%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    XORTX Therapeutics does not currently pay a dividend.

  • Dividend Growth

    XORTX Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.08% of the float of XORTX Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    XORTX Therapeutics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in XORTX Therapeutics has recently decreased by 75.86%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for XORTX Therapeutics this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for XRTX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, XORTX Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.90% of the stock of XORTX Therapeutics is held by insiders.

  • Percentage Held by Institutions

    Only 0.23% of the stock of XORTX Therapeutics is held by institutions.

  • Read more about XORTX Therapeutics' insider trading history.
Receive XRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XORTX Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

XRTX Stock News Headlines

XRTX XORTX Therapeutics Inc. - Seeking Alpha
XORTX Announces USD $925,000 Private Placement
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
XORTX Announces USD $3 Million Offering
XORTX Therapeutics Inc (XRTX) Gets a Buy from Alliance Global Partners
See More Headlines

XRTX Stock Analysis - Frequently Asked Questions

XORTX Therapeutics Inc. (NASDAQ:XRTX) released its quarterly earnings results on Thursday, May, 15th. The technology company reported ($0.19) EPS for the quarter.

XORTX Therapeutics's stock reverse split on Friday, November 10th 2023.The 1-9 reverse split was announced on Friday, November 10th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that XORTX Therapeutics investors own include NVIDIA (NVDA), Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN) and EUDA Health (EUDA).

Company Calendar

Last Earnings
5/15/2025
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
NASDAQ:XRTX
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.31 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.88 per share
Price / Book
1.02

Miscellaneous

Free Float
3,527,000
Market Cap
$3.41 million
Optionable
Not Optionable
Beta
0.51
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:XRTX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners